Drug Trial Radar · NCT00149188
Somatuline Autogel: Acromegaly Self/Partner Injection Study
Last checked: Nov 20, 2026Latest source record: Aug 5, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
30
Actual
Start
Feb 2004
Primary completion
Aug 24, 2005
Study completion Aug 24, 2005
Sponsor
- Lead sponsor
- IpsenIndustry
- Sponsor type
- Industry
- First posted
- Sep 8, 2005
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to allow patients with acromegaly, or their partners, to learn how to successfully inject Somatuline Autogel at home. Ability to perform unsupervised injections whilst maintaining adequate disease control will be assessed.
Conditions
- Acromegaly
Interventions
Lanreotide (Autogel formulation)Drug
Primary outcomes
What the sponsor says the trial is designed to measure.
- To assess the ability of patients or their partners to perform unsupervised Somatuline Autogel injections.
Locations
10 sites in 1 country. Site status is shown where the registry gives one.
Dept of Endocrinology, Aberdeen Royal Infirmary
Aberdeen, United Kingdom
Department of Medicine, Queen Elizabeth Hospital
Birmingham, United Kingdom
Department of Endocrinology, Coventry & Warwickshire Hospital
Coventry, United Kingdom
Department of Endocrinology, Leicester Royal Infirmary
Leicester, United Kingdom
Department of Endocrinology, Manchester Royal Infirmary
Manchester, United Kingdom
The Oxford Centre for Diabetes, Endocrinology and Metabolism, The Churcill Hospital
Oxford, United Kingdom
Department of Endocrinology, Royal Hallamshire Hospital
Sheffield, United Kingdom
Department of Endocrinology, Sunderland Royal Hospital
Sunderland, United Kingdom
Michael White Centre Diabetes & Endocrinology, Hull Royal Infirmary
Hull, East Yorkshire, United Kingdom
Department of Endocrinology, The Royal Free Hospital
Hampstead, London, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.